Screener
Vera Therapeutics VERA Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 122,042 | 130,212 |
| Stockholders’ equity | ||
| Class A common stock, $0.001 par value; 500,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 71,730,090 and 71,267,429 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 72 | 71 |
| Additional paid-in capital | 1,381,678 | 1,364,529 |
| Accumulated other comprehensive (loss) income | (156) | 786 |
| Accumulated deficit | (881,897) | (760,865) |
| Total stockholders’ equity | 499,697 | 604,521 |
| Total liabilities and stockholders’ equity | $621,739 | $734,733 |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's total liabilities & equity?
- Vera Therapeutics (VERA) reported total liabilities & equity of $621.74M in Q1 2026.
- How has Vera Therapeutics's total liabilities & equity changed year-over-year?
- Vera Therapeutics's total liabilities & equity increased by 1.9% year-over-year, from $610.17M to $621.74M.
- What is the long-term trend for Vera Therapeutics's total liabilities & equity?
- Over 5 years (2020 to 2025), Vera Therapeutics's total liabilities & equity has grown at a 68.2% compound annual growth rate (CAGR), from $54.55M to $734.73M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Vera Therapeutics's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude